☆ 4.6 Letter

Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 96, Issue 8, Pages E269-E272

Publisher

WILEY
DOI: 10.1002/ajh.26201

Keywords

-

Categories

Hematology

Funding

  1. Associazione Italiana Ricerca sul Cancro (AIRC) Grant 5xmille [9980]
  2. AIRC [16695]
  3. Fondazione CaRiCal [16695]
  4. Associazione Italiana Ricerca Cancro (AIRC), Investigator Grant [IG-21687, IG-5506]
  5. Progetto Ricerca Finalizzata, Ministero della Salute, Rome, Italy [PE 2016-02362756, RF-2018-12365790]
  6. Compagnia S. Paolo, Turin, Italy [2017.0526]
  7. AIRC 5x1000 [21198]
  8. MoH, Rome, Italy [RF-2018-12365790]
  9. GILEAD Sciences Srl.
  10. Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy
  11. Ministry of Health

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.